About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Organizations Butler
Research Type Clinical
Therapeutic Area of Study Parkinson's Disease/Movement Disorders
Eligibility Criteria Male or female 30 years or older with early Parkinson’s disease who are not yet on treatment for Parkinson’s
Recruitment Status Open
Date Study Started 07/01/2007
Date Study Ends 07/01/2014
Contact Information

For more information contact Lisa at 401-455-6667.

Description

This study is using oral inosine to try to slow the progression of Parkinson’s disease in those with early PD. Inosine raises serum uric acid, which, by strong epidemiological evidence, is associated with reduced incidence of PD and slow progression. This study lasts approximately 2 years with 16 visits over that time period. This study is sponsored by the Michael J. Fox Foundation

Look for another study
Health Headlines
Dozens in Dallas Said to Be Free of Ebola RiskView in a lightbox
Ebola or Not? Rapid Test for the Virus Not Here YetView in a lightbox
Goodbye to Reading Glasses?View in a lightbox
Scientists Grow, Implant Human Intestinal Tissue in MiceView in a lightbox
Regular Doctor Visits Help Control Blood Pressure, Study SaysView in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices | Talks Your Health